Leadership & Team
ELIQUENT Japan proudly offers extensive experience in regulatory consulting and stakeholder alignment in the Japanese pharmaceutical market. Our leadership and team are comprised of industry experts and practitioners committed to helping our clients gain expedient entry into Japan.
Meet Our Leadership
Naoya Kato, MSc
Representative Director and CEO
Yasue Ishida, MBA
Director, Finance & HR
Mikio Ishizawa
Director, Product Planning & Commercial Planning
Shunsuke Iwano, PhD
Director, Development Planning
What makes IDEC different?
Non-Clinical
Our team is comprised of specialists in pharmacology, pharmacokinetics, and toxicity, and have been engaged in drug research and development for many years at both domestic and international pharmaceutical companies.
Clinical Team
Experienced in drug research and clinical development at domestic and international pharmaceutical companies, our Clinical team members have expertise in pharmacokinetics, pharmacodynamics, and statistics.
CMC Team
The IDEC team offers CMC expertise across biopharmaceuticals, blood products, human-derived hormone products, and chemically synthesized drugs.
Medical Writing Team
Across disciplines, the IDEC team is experienced and versed in the creation of clinical trial-related documents, application materials, consultation materials, and inquiry correspondence.
Development Compliance Team
With team members serving international pharmaceutical companies and engaged in drug development for more than 30 years, IDEC has experts ready with extensive experience in compliance.
In-House Medical Team
IDEC boasts a unique skill set within its own virtual walls: an in-house medical expert who obtained a license in both Germany and Japan and served as a clinical physician in a Japanese hospital.
Learn how our proven services and process can help you accelerate your product’s path to market.
